Elysium Medical Group - Dr. Mahnaz Qayyum

Elysium Medical Group in Orlando, Florida, operates under the medical direction of Dr. Mahnaz Qayyum, M.D., combining primary care services with specialized peptide therapy and metabolic medicine. The practice addresses chronic disease management alongside advanced weight loss protocols, serving patients throughout the greater Orlando area who require both routine medical oversight and targeted interventions for metabolic dysfunction. Dr. Qayyum's approach integrates conventional primary care with peptide-based treatments, allowing patients to receive comprehensive medical management under a single provider rather than fragmenting care across multiple specialists.

The clinic's peptide therapy program centers on three primary compounds: semaglutide and tirzepatide for metabolic optimization and weight reduction, and sermorelin for growth hormone support. Semaglutide, a GLP-1 receptor agonist, works by enhancing insulin secretion and reducing appetite through central nervous system pathways, while tirzepatide functions as a dual GIP/GLP-1 receptor agonist with enhanced metabolic effects. Sermorelin, a growth hormone-releasing hormone analog consisting of the first 29 amino acids of GHRH, stimulates the pituitary gland's natural production of growth hormone rather than replacing it directly. These peptides are prescribed as part of structured medical weight loss programs that include metabolic assessment, body composition analysis, and ongoing monitoring. The practice also provides bio-identical hormone replacement therapy, addressing thyroid dysfunction, menopause, andropause, and adrenal insufficiency through hormone optimization protocols that may incorporate peptide support.

Dr. Mahnaz Qayyum brings her medical degree and primary care training to a practice model that emphasizes continuity of care for patients with complex metabolic conditions. Her background in primary care allows for comprehensive evaluation of patients before initiating peptide therapy, including assessment of cardiovascular risk factors, diabetes screening, and identification of contraindications. The practice's structure as a primary care office with specialized services means patients can address acute medical needs, manage chronic conditions like hypertension and diabetes, and pursue peptide-based interventions within the same clinical relationship. This integration proves particularly valuable for patients whose weight management or hormone concerns intersect with other medical conditions requiring coordinated treatment.

Patients at Elysium Medical Group in Orlando undergo initial consultations that include medical history review, physical examination, and laboratory assessment to establish baseline metabolic markers before beginning peptide therapy. The practice requires in-person visits, allowing for direct clinical evaluation and hands-on instruction for self-administered peptide injections. Follow-up protocols typically include regular weight checks, body composition measurements, and periodic lab work to monitor treatment response and adjust dosing. The office environment combines primary care functionality with aesthetic and wellness services, creating a hybrid model where patients may receive preventive care, chronic disease management, and elective metabolic optimization. Nurse practitioners support the practice operations, extending access for routine visits while Dr. Qayyum oversees complex cases and treatment protocols.

Elysium Medical Group's location in Orlando positions the practice to serve Central Florida residents seeking integrated medical care that extends beyond standard primary care offerings. The practice's combination of conventional medicine with peptide therapy and hormone optimization addresses a patient population interested in proactive metabolic health management rather than reactive disease treatment. Patients maintain an ongoing relationship with a primary care physician who understands both their baseline health status and their optimization goals, eliminating the need to coordinate between separate providers for medical clearance and specialized treatments. This model particularly benefits individuals managing multiple metabolic conditions who require both medical oversight and advanced interventions, providing a single point of contact for comprehensive care planning in the Orlando area.